Hrt Financial LP Siga Technologies Inc Transaction History

Hrt Financial LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$6.32 - $10.46 $144,532 - $239,209	22,869 New	22,869 $173,000
Q1 2023 May 12, 2023	BUY	$5.23 - $8.42 $360,796 - $580,862	68,986 New	68,986 $396,000
Q3 2022 Nov 14, 2022	BUY	$10.02 - $26.15 $110 - $287	11 Added 0.09%	12,530 $129,000
Q2 2022 Aug 12, 2022	BUY	$6.5 - $13.68 $81,373 - $171,259	12,519 New	12,519 $144,000
Q1 2022 May 16, 2022	SELL	$5.96 - $7.61 $277,044 - $353,743	-46,484 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$6.96 - $9.26 $32,475 - $43,207	-4,666 Reduced 9.12%	46,484 $349,000
Q3 2021 Nov 15, 2021	BUY	$5.71 - $7.39 $18,591 - $24,061	3,256 Added 6.8%	51,150 $377,000
Q2 2021 Aug 16, 2021	BUY	$6.1 - $7.58 $196,298 - $243,924	32,180 Added 204.79%	47,894 $300,000
Q1 2021 May 17, 2021	BUY	$6.3 - $7.71 $98,998 - $121,154	15,714 New	15,714 $102,000
Q4 2020 Feb 16, 2021	SELL	$6.39 - $7.76 $392,786 - $476,999	-61,469 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$5.62 - $7.68 $345,455 - $472,081	61,469 New	61,469 $422,000

185

35.6M

873K

466K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $438M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.